At a glance
ClinicalIndex Comparison RecordN/ACompleted· 135 enrolled
Drug / intervention
propofol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Propofol and Sevoflurane as a Primary Anesthetic for Cardiac Ablation of Atrial Fibrillation.
In Brief
A clinical study evaluating propofol and sevoflurane for Atrial Fibrillation. Completed, enrolled 135 participants across 1 site.
Detailed Summary
Comparison of propofol and sevoflurane as a primary anesthetic for cardiac ablation of atrial fibrillation
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 2016
Enrollment StartJun 2016
Primary CompletionJun 2023
Study CompletionFeb 2024
TodayJul 2026
First PostedMar 3, 2016
Enrollment StartJun 8, 2016
Primary CompletionJun 30, 2023
Study CompletionFeb 28, 2024
TodayJul 2, 2026
Enrollment to primary: 7.1 yearsPosted 10.3 years ago
Interventions
propofoldrug
Participant receives propofol as anesthetic for cardiac ablation.
sevofluranedrug
Participant receives sevoflurane as anesthetic for cardiac ablations.